Why Dose Timing Can Differ From Effect Timing
A drug can be absorbed or distributed into plasma before its pharmacological effect has fully developed. If a therapeutic effect is needed at a particular time, administering the dose at that time may therefore be too late. The effect-compartment model gives a simple, explicit description of this delay: the effect site is driven toward the plasma concentration, but approaches it over time rather than instantaneously.
The model can convert an intended effect time into a dose time, provided the pharmacokinetic input and the effect-site equilibration rate are known or estimated. The timing calculation is not a universal correction such as “dose one hour earlier.” The lag depends on the drug's elimination, the rate of equilibration, the dosing history, and the criterion used to define the desired effect.
This representation assumes that the plasma-to-effect-site delay can be approximated by a single first-order process, that \(k_{e0}\) is constant over the period considered, and that the effect site does not feed back on plasma concentrations. For the calculations below, bolus doses produce an instantaneous concentration increment in a one-compartment plasma model, and plasma elimination is first order with rate constant \(k\). These are modeling assumptions, not claims that every drug has instantaneous absorption or one-compartment disposition.
Single-Dose Effect-Course and Peak Time
After a bolus dose \(D\), let the initial plasma concentration increment be \(C_0=D/V\), where \(V\) is the apparent volume of distribution. With \(C_p(t)=C_0e^{-kt}\) and \(C_e(0)=0\), the effect-compartment equation has the solution
The difference between the two exponentials produces the delay: the effect-site concentration starts at zero, rises as plasma concentration drives it, and later falls as the input wanes. To find its peak, differentiate the expression and set the derivative to zero. The positive-time solution is
This expression is positive whether \(k_{e0}>k\) or \(k_{e0}<k\), and it gives the time after the dose at which \(C_e(t)\) peaks. If \(k_{e0}=k\), taking the limit in the concentration formula gives \(C_e(t)=C_0 k t e^{-kt}\), whose peak occurs at \(t_{\max}=1/k\). These results identify the peak of the modeled effect-site concentration. They identify the peak of the pharmacological response only if response increases with \(C_e\) over the relevant range and there is no additional delay or response hysteresis.
Worked Example: Aligning a Single-Dose Effect Peak
Suppose, hypothetically, a bolus dose gives \(C_0=10.0\) mg/L, the plasma elimination rate is \(k=0.200\) h\(^{-1}\), and \(k_{e0}=0.500\) h\(^{-1}\). Find the effect-site peak time and choose a dose time if the effect peak is needed at 08:00.
The single-bolus model applies under the stated first-order assumptions, with \(k_{e0}\ne k\). Thus
The peak effect-site concentration is
For a peak at 08:00, administer approximately 3.054 hours earlier: \(08{:}00-3.054\ \mathrm{h}\approx04{:}57\). This is a model-based timing calculation, not evidence that the dose is safe or that this peak concentration is therapeutically appropriate. It also assumes no meaningful residual contribution from earlier doses.
Repeated Doses: Residual Effect Changes the Peak
When doses repeat, the effect-site concentration from previous doses remains part of the current profile. For equal bolus doses every \(\tau\) hours, linearity allows the steady-state effect-site concentration to be written as the sum of the contributions from the current and all earlier doses. For \(0\leq t<\tau\), where \(t\) is time since the most recent dose,
The denominators are geometric-series accumulation factors. Differentiating this expression and setting the derivative equal to zero gives the steady-state peak time:
This time is measured from each dose, and a peak within the interval requires the calculated time to lie between 0 and \(\tau\). The formula is not interchangeable with the single-dose peak formula: the accumulated contribution from earlier doses changes the shape and timing of the steady-state profile.
Worked Example: Timing a Repeated Daily Dose
Use the hypothetical parameters \(k=0.200\) h\(^{-1}\), \(k_{e0}=0.500\) h\(^{-1}\), and a 24-hour dosing interval. Find the steady-state effect peak time and the daily administration time for a peak at 08:00.
The repeated-dose steady-state formula assumes linear superposition and the same dose every 24 hours. Its log argument is
Therefore,
A steady-state peak at 08:00 therefore calls for an administration time of about \(08{:}00-3.0268\ \mathrm{h}=04{:}58\). The peak is slightly earlier after repeated daily dosing than after one isolated dose, because the residual effect from prior doses changes the summed profile. A model calculation of timing should use the dosing history that will actually apply, rather than automatically reusing the single-dose lag.
Aligning a Therapeutic Threshold Window
A therapeutic need is often a period rather than a single peak time. Suppose the response is considered adequate whenever \(C_e(t)\geq C_{\mathrm{target}}\), and the response increases monotonically with effect-site concentration over the range of interest. The model then predicts an onset time and an offset time by solving \(C_e(t)=C_{\mathrm{target}}\) on the rising and falling limbs. If these are \(t_{\mathrm{on}}\) and \(t_{\mathrm{off}}\), a dose at time \(T_d\) gives a predicted adequate-effect interval from \(T_d+t_{\mathrm{on}}\) to \(T_d+t_{\mathrm{off}}\).
A single dose can cover a required interval \([T_1,T_2]\) only if its predicted threshold interval is long enough and can be shifted to include both endpoints. In particular, its duration \(t_{\mathrm{off}}-t_{\mathrm{on}}\) must be at least \(T_2-T_1\). Choosing the dose time to align the peak alone does not guarantee adequate effect at the start or end of the required period.
Worked Example: Covering a Specified Period of Need
For the hypothetical single-dose profile in the first example, suppose adequate effect is defined as \(C_e\geq4.00\) mg/L, and therapeutic coverage is needed from 09:00 to 14:00. Estimate the threshold crossing times and select a dose time.
The concentration formula and parameter assumptions are unchanged. Numerically solving
gives a rising crossing at approximately \(t_{\mathrm{on}}=1.22\) h and a falling crossing at approximately \(t_{\mathrm{off}}=6.32\) h. The predicted time above the threshold is about \(6.32-1.22=5.10\) h, which is longer than the five-hour need. Set the rising crossing to 09:00 by dosing \(1.22\) hours earlier:
The predicted threshold interval is then about 09:00 to 14:06, so it covers the requested 09:00–14:00 period under the model. The margin at the end is only about six minutes; rounding, parameter uncertainty, variable absorption, or a poorly calibrated threshold could remove it. A practical recommendation should account for such uncertainty and operational constraints rather than treating the calculated clock time as exact.
Calculation Checks, Alternatives, and Limitations
A useful diagnostic is to plot or tabulate \(C_p(t)\) and \(C_e(t)\) over the full dosing interval, including previous doses when relevant. The effect compartment should respond smoothly and lag changes in plasma concentration; it should not jump at a bolus administration. Check that the calculated peak lies in the interval being analyzed, that the threshold equation has the claimed rising and falling roots, and that the resulting dose time actually places the predicted coverage over the required clock times.
If observations show a different delay, a plateau, a prolonged response after \(C_e\) falls, or a response that depends on the direction of concentration change, a single effect compartment may be inadequate. Such patterns can reflect an incorrect PK profile, an inappropriate \(k_{e0}\), an indirect response mechanism, tolerance, active metabolites, or a response relation that is not monotone. Fitting a lag solely to make one observed peak line up can conceal these model failures.
The main alternatives answer different questions. Timing from the plasma concentration peak is appropriate only when the effect is effectively immediate or when plasma concentration itself is the chosen target. An empirically estimated time lag can be a practical approximation, but it may not transfer across dose levels or intervals. The effect-compartment approach makes the delay dynamic and allows prior doses to contribute, but it relies on the assumed PK input and equilibration model. It does not by itself select dose amount, guarantee a clinically meaningful response threshold, or resolve uncertainty in patient-specific parameters.
The timing recommendation is particularly sensitive when the desired coverage nearly equals the predicted time above threshold. In that case, small changes in \(k\), \(k_{e0}\), dose absorption, or the concentration-response relationship can shift onset and offset appreciably. Report the assumptions and uncertainty alongside a proposed administration time, and verify the prediction with an appropriate model and clinical evidence before treating it as a dosing instruction.
Check Your Understanding
Answer each question using the model assumptions stated in the tutorial. Brief solutions follow the questions.
- For \(k=0.25\) h\(^{-1}\) and \(k_{e0}=0.50\) h\(^{-1}\), calculate the single-dose effect-site peak time.
- Why can the steady-state peak time differ from the isolated-dose peak time?
- A modeled threshold interval lasts 4.2 hours. Can a single dose cover a required six-hour period? Explain.
- What does a jump in measured effect-site concentration exactly at bolus administration suggest about the modeled profile?
- Name one assumption that must hold for aligning the peak of \(C_e\) to align the peak therapeutic response.
Solutions. (1) \(t_{\max}=\ln(0.50/0.25)/(0.50-0.25)=\ln(2)/0.25=2.773\) h. (2) Earlier doses contribute residual effect, changing the summed concentration profile and its derivative. (3) No: a 4.2-hour threshold interval is shorter than the required six hours, so shifting dose time cannot cover both endpoints. (4) The effect compartment should not jump after a bolus; the observation or model may be inconsistent with the assumed compartment dynamics. (5) The response must increase monotonically with \(C_e\) over the relevant range, with no additional response delay or hysteresis that shifts its peak.